This research finds a 94.12% degradation of tetracycline hydrochloride in water using a copper–iron bioxide-activated persulfate system, highlighting its efficiency for wastewater treatment.
Advanced oxidation processes (AOPs) utilizing peroxymonosulfate (PMS) have emerged as a promising technology for organic pollutant degradation due to their distinct environmental advantages. In this study, copper–iron bimetallic oxide catalysts with varying ratios were synthesized via a co-precipitation method to activate PMS for degrading simulated tetracycline hydrochloride wastewater. The catalysts were characterized by scanning electron microscopy (SEM), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), and X-ray photoelectron spectroscopy (XPS). The effects of key parameters—including the PMS concentration, catalyst dosage, initial pH, and tetracycline hydrochloride concentration—on the degradation efficiency were systematically investigated. The results demonstrated that the CuFe(2)/PMS system exhibited the highest degradation efficiency. Under optimal conditions (20 mg/L tetracycline hydrochloride, 0.4 mM PMS, 0.5 g/L CuFe(2) catalyst, and pH 3), this system achieved a 94.12% degradation rate of tetracycline hydrochloride within 120 min. The electron paramagnetic resonance (EPR) tests and radical quenching experiments identified sulfate radicals (SO4·−) as the predominant reactive species. Furthermore, the XPS analysis elucidated the persulfate activation mechanism, while the liquid chromatography–mass spectrometry (LC-MS) identified the potential degradation pathways and intermediate products of tetracycline hydrochloride.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: